Shares of Phibro Animal Health Co. (NASDAQ:PAHC - Get Free Report) were up 6% during mid-day trading on Monday . The company traded as high as $24.17 and last traded at $24.11. Approximately 73,421 shares were traded during trading, a decline of 68% from the average daily volume of 228,856 shares. The stock had previously closed at $22.74.
Wall Street Analyst Weigh In
A number of research firms have recently commented on PAHC. Barclays raised their price target on Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a report on Monday, February 10th. StockNews.com downgraded Phibro Animal Health from a "strong-buy" rating to a "buy" rating in a research note on Thursday, February 6th. Finally, Morgan Stanley upped their price target on Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a research report on Tuesday, December 17th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $21.00.
Check Out Our Latest Research Report on Phibro Animal Health
Phibro Animal Health Stock Performance
The firm has a market capitalization of $944.12 million, a PE ratio of 48.56, a PEG ratio of 0.45 and a beta of 0.52. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. The company has a 50-day moving average of $22.42 and a 200 day moving average of $22.44.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Equities research analysts predict that Phibro Animal Health Co. will post 1.95 EPS for the current year.
Phibro Animal Health Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 2.06%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health's dividend payout ratio (DPR) is currently 100.00%.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the company. Mackenzie Financial Corp bought a new stake in Phibro Animal Health in the fourth quarter valued at approximately $478,000. Public Employees Retirement System of Ohio bought a new stake in Phibro Animal Health during the 4th quarter valued at $323,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Phibro Animal Health by 37.1% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 62,566 shares of the company's stock valued at $1,314,000 after buying an additional 16,917 shares during the period. Virtus Fund Advisers LLC bought a new stake in Phibro Animal Health in the 4th quarter worth $69,000. Finally, Virtus Investment Advisers Inc. increased its position in shares of Phibro Animal Health by 103.4% in the fourth quarter. Virtus Investment Advisers Inc. now owns 49,504 shares of the company's stock valued at $1,040,000 after acquiring an additional 25,160 shares during the period. Institutional investors own 99.34% of the company's stock.
About Phibro Animal Health
(
Get Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Read More
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
